4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients.
The Director, Financial Planning and Analysis - TechOps serves as the primary finance business partner to the TechOps organization, providing end-to-end financial leadership across Manufacturing, Supply Chain, CMC Quality, and External Manufacturing as 4DMT transitions from late-stage clinical development to commercial readiness and launch.
4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients.
Encoded Therapeutics